PB

Pavani Bommareddy

Director Director DIN 03579459
DIN 03579459 First appointment Nov 2004 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Nov 2004
Shareholding value Locked Premium profile

About Pavani Bommareddy

Pavani Bommareddy has 21 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 03579459
Primary Designation Director
First Appointment 11 Nov 2004
Oldest Company Age 21 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Innomorph Drugs Private Limited U24239TG2004PTC044602
Director 11 Nov 2004 2004 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Innomorph Drugs Private Limited
Premium access

Shareholding and investment profile for Pavani Bommareddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pavani Bommareddy

Pavani Bommareddy has 21 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Pavani Bommareddy is associated with 0 companies as Director.

Pavani Bommareddy has expertise in General Business.

Pavani Bommareddy has 21 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available